Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations... Show more
Red Cat Holdings occupies a strategically valuable niche as a U.S.-based manufacturer of defense and national-security robotics. Its Family of Systems — anchored by the Black Widow sUAS and the FANG FPV strike drone — is built to comply with National Defense Authorization Act (NDAA) restrictions that bar the use of Chinese-sourced components, a qualification increasingly central to U.S. procurement decisions.
The company's competitive moat rests on three pillars: domestically controlled manufacturing that can scale rapidly, a modular open-systems architecture that allows fast iteration, and an all-domain footprint spanning air, land, and sea. Through subsidiaries Teal Drones and FlightWave Aerospace, and the newer Blue Ops maritime unit, Red Cat is positioning itself as a "trusted supplier" capable of volume delivery rather than a niche developer.
That positioning cuts both ways. On one hand, government customers increasingly favor vendors with genuine domestic production capacity. On the other, the market is crowded, and the competitive gauntlet system used by the Pentagon — field trials that progressively eliminate vendors — means structural positioning must be repeatedly converted into tangible contract wins. Red Cat's ability to do so will define its medium-term trajectory far more than near-term share-price fluctuations.
The single most consequential near-term catalyst is the progression of the DoD's Drone Dominance Program. Red Cat's Teal Drones unit advanced as one of 12 finalists in early field trials, and the program is structured to whittle suppliers down to roughly five by early 2027 through successive "gauntlet" evaluations. The outcome of these rounds will directly shape revenue visibility.
That path is not without setbacks. In the most recent Gauntlet II results, Red Cat was not selected, with Xtend AI Robotics emerging as the only public-company winner. Northland Securities responded by lowering its price target to $13 from $15 while maintaining an Outperform rating, trimming fiscal 2026 and 2027 revenue estimates — a signal that execution and award conversion remain the market's central concern.
Other catalysts include upcoming quarterly earnings, which will test whether the company's 849% year-over-year first-quarter revenue growth can be sustained; potential international orders across allied and Indo-Pacific markets; the maturation of the Blue Ops USV line, where higher average selling prices could add meaningful upside; and further strategic acquisitions, following deals for Apium Swarm Robotics and Quaze Technologies.
On the ratings front, sentiment has become more nuanced. Recent initiations and revisions span a wide range — Piper Sandler at Hold with a $9 target, Evercore ISI at Buy with $15, Clear Street at Buy with $19, and Roth MKM at Buy with $25 — illustrating both long-term optimism and near-term caution around valuation and execution.
Red Cat's outlook is tightly coupled to the global defense-spending cycle and the accelerating adoption of low-cost, attritable (expendable) drones, a lesson reinforced by the war in Ukraine. The "Unleashing American Drone Dominance" executive order and rising interest in domestic drone manufacturing have created a structural tailwind for NDAA-compliant suppliers.
Fiscal policy is a double-edged sensitivity. Congressional budget negotiations, continuing resolutions, and potential increases to the fiscal 2027 DoD budget can either accelerate or delay procurement. End-of-fiscal-year "sweeps" spending can pull demand forward, while continuing resolutions can defer it — injecting volatility into quarterly results that is often unrelated to underlying demand.
Interest rates and capital-market conditions matter as well. As a cash-burning, early-stage defense contractor, Red Cat has relied on equity raises to fund inventory, facilities, and capacity expansion. Higher financing costs or investor aversion to dilution could pressure both its cost of capital and shareholder returns, even as its operational trajectory improves.
For traders seeking a data-driven read on where RCAT may head next, Tickeron's Trend Prediction Engine offers an AI-powered forecasting tool that helps identify whether a stock, exchange-traded fund (ETF), or other asset may trend bullish, bearish, or sideways over the coming week or month. The engine is designed to surface developing trends, flag possible breakouts or reversals, and let users explore predictions across a broad universe of tradable instruments, supported by searchable categories, historical context, and alert-oriented functionality. As contract-driven news flow continues to move shares, pairing fundamental analysis with signal-based tools can help investors track momentum more systematically.
Looking toward 2026 and beyond, Red Cat's long-term story hinges on its ability to convert program-of-record status into repeatable, growing revenue. Consensus forecasts point to a sharp revenue ramp — from roughly $40.7 million in fiscal 2025 toward the $150–$180 million guided for 2026 — with margin expansion expected as production volumes absorb fixed costs and higher-value software content is layered into the platform mix.
Structural themes worth monitoring include the maturation of the U.S. domestic drone supply chain, the shift toward swarming and autonomous systems that reduce operator burden, and the international diffusion of battlefield drone demand. The maritime opportunity through Blue Ops represents a potentially significant expansion lever given the higher average selling prices of uncrewed surface vessels.
At the same time, competitive threats are intensifying, with rival vendors vying for the same limited contract slots. Capital allocation will remain a focal point: the company's strengthened cash position gives it flexibility to invest in capacity and bolt-on acquisitions, but dilution from prior equity offerings has already tempered some analyst price targets. How management balances growth investment against shareholder value will be central to sustaining long-term sentiment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, RCAT has been loosely correlated with KTOS. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if RCAT jumps, then KTOS could also see price increases.
| Ticker / NAME | Correlation To RCAT | 1D Price Change % | ||
|---|---|---|---|---|
| RCAT | 100% | -2.37% | ||
| KTOS - RCAT | 64% Loosely correlated | +1.03% | ||
| RDW - RCAT | 62% Loosely correlated | -1.84% | ||
| DPRO - RCAT | 62% Loosely correlated | -3.72% | ||
| LUNR - RCAT | 60% Loosely correlated | -3.72% | ||
| ACHR - RCAT | 58% Loosely correlated | +5.08% | ||
More | ||||
| Ticker / NAME | Correlation To RCAT | 1D Price Change % |
|---|---|---|
| RCAT | 100% | -2.37% |
| Aerospace & Defense industry (86 stocks) | 39% Loosely correlated | -0.41% |
Industry AerospaceDefense
The 10-day moving average for RCAT crossed bearishly below the 50-day moving average on September 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for RCAT turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 35 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for RCAT entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
RCAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.107) is normal, around the industry mean (6.305). P/E Ratio (0.730) is within average values for comparable stocks, (58.116). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (2.564). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (11.820) is also within normal values, averaging (18.330).
The Tickeron Profit vs. Risk Rating rating for this company is 81 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. RCAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.